Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook

Goldman Sachs has raised its year-end S&P 500 forecast to 6,900 from 6,500, citing renewed optimism for economic resilience, stabilizing inflation, and anticipated Federal Reserve rate cuts, a sentiment echoed by Bank of America which also increased its target to 6,300. The firm projects S&P 500 earnings-per-share to grow by 7% this year and next, driven by strong fundamentals, while acknowledging risks from the shifting tariff landscape. Concurrently, Goldman highlighted three specific stock opportunities for the second half of 2025: Kohl's (a deep value retail play), Intellia Therapeutics (a gene-editing growth opportunity), and Gogo Inc. (a small-cap leader in in-flight connectivity).

Analysis

Major investment banks are recalibrating their market outlooks, with Goldman Sachs leading the bullish charge by raising its year-end S&P 500 forecast to 6,900, anticipating a 9% gain from current levels. This optimism is underpinned by projections of 7% EPS growth for both the current and subsequent year, driven by strong consumer demand, margin expansion, and the expectation of earlier and deeper Federal Reserve interest rate cuts. Bank of America also lifted its target to a more conservative 6,300, citing potential headwinds from slowing tech earnings. Goldman acknowledges that a shifting tariff landscape presents a significant risk to earnings forecasts. Against this backdrop, the firm has identified three distinct investment opportunities. Kohl's (KSS) is presented as a deep-value, contrarian play, trading down 33.4% year-to-date but benefiting from a turnaround strategy, a 5.39% dividend yield, and a capital structure poised to benefit from lower interest rates. Intellia Therapeutics (NTLA) represents a high-growth opportunity in the gene-editing sector, with its stock having surged 45.3% in the past month, partly buoyed by M&A activity in its field. Finally, Gogo Inc. (GOGO), a small-cap leader in in-flight connectivity, is highlighted for its growth potential, having risen 117% over the past three months on the back of a major FAA certification for its 5G network rollout, which now covers 70% of its North American customer aircraft inventory.

Key Decisions for Investors

• Given the broad market optimism from major banks, investors could consider maintaining or increasing exposure to US equities, while closely monitoring tariff news and macroeconomic data as key potential risks to the bullish thesis.
• For value-oriented investors with a higher risk tolerance, Kohl's offers a contrarian opportunity with a significant dividend, but its success is contingent on both its internal turnaround and the timing of Fed rate cuts.
• Investors seeking high-growth exposure could evaluate Intellia Therapeutics, understanding its potential is tied to the high-risk, high-reward nature of early-stage clinical biotech, which has recently seen positive sector sentiment.
• Gogo Inc. presents a targeted growth opportunity in aviation technology, driven by a clear 5G rollout catalyst and strong recurring revenue, though its recent 117% surge warrants a careful evaluation of the entry point.